Sort
16,300 grants matching “fatty liver disease”
Glucose And BCAA Metabolism in the Heart
$774,754Rong Tian · University Of Washington · R01 · FY2014 · HL
Understanding the Impact of Early Life Factors on Cardiometabolic Risk throughout the Life Course in a Large and Diverse Cohort of Adolescents and Young Adults
$774,229Ai Kubo · Kaiser Foundation Research Institute · R01 · FY2025 · HL
Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease
$773,997Carlos Fernandez Hernando · Yale University · R01 · FY2024 · HL
IDOL and dyslipidemia in cardiovascular diseases
$773,938Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
IDOL and dyslipidemia in cardiovascular diseases
$773,938Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
IDOL and dyslipidemia in cardiovascular diseases
$773,938Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2019 · HL
IDOL and dyslipidemia in cardiovascular diseases
$773,938Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Food Insecurity and Diet Quality: Effects on Liver Disease in People with HIV
$773,341Ani Kardashian · University Of Southern California · K23 · FY2025 · DK
The Role of Iron in the Pathogenesis of NAFLD
$773,137Kris Kowdley · Benaroya Research Inst At Virginia Mason · R01 · FY2011 · DK
Hispanic Latino Lipid Consortium
$772,763Kari E North · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults
$772,730Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2023 · DK
The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis
$772,607Amir Zarrinpar · University Of California, San Diego · R01 · FY2022 · HL
A Model for Human Liver Fibrosis
$772,327Gary A Peltz · Stanford University · R56 · FY2022 · DK
Pathways of Tissue Lipid Uptake
$771,719Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2022 · HL
Food Prescriptions to Promote Affordable Diets that Meet RDAs Among Multi-Generational Latino Households
$770,645Deborah A Cohen · Children'S Hospital Of Los Angeles · P50 · FY2021 · MD
Hispanic Latino Lipid Consortium
$770,456Kari E North · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Pathways of Tissue Lipid Uptake
$770,444Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2023 · HL
Obesity, Inflammation, and Lung Injury After Lung Transplantation
$770,219David J. Lederer · Columbia University Health Sciences · R01 · FY2014 · HL
The role of signaling adaptor protein epsin in atherosclerosis
$770,203Hong Chen · Boston Children'S Hospital · R01 · FY2024 · HL
PDGFR and KDR Inhibitors for Liver Fibrosis
$769,978Prakash Narayan · Angion Biomedica Corporation · R44 · FY2014 · DK
"Validation of Novel CKD Biomarkers in CRIC"
$769,896Chi-Yuan Hsu · University Of California, San Francisco · U01 · FY2010 · DK
Physiologic Consequence of Genetic Variation
$769,738Richard M Watanabe · University Of Southern California · R01 · FY2019 · DK
Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy
$769,710Grace A McComsey · Case Western Reserve University · R01 · FY2020 · DK
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity
$769,627Richard Joseph Johnson · Colorado Research Partners, Llc · R42 · FY2018 · DK
Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites
$768,896Bina Joe · University Of Toledo Health Sci Campus · R01 · FY2024 · HL